Search research articles
Contact Us
Filters
Showing results (81-90 of 192) with videos related to
Page
of 20
Sort By:
Bulletin Du Cancer
|
July 1, 2014
[A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blocker]
Marie Wislez, David Malka, Jaafar Bennouna, et al.
Anti-Cancer Drugs
|
December 12, 2018
5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy
Alice Boilève, Camille Wicker, Benjamin Verret, et al.
Oncology
|
January 25, 2012
Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study
Maximilien Barret, David Malka, Thomas Aparicio, et al.
Annals of Surgical Oncology
|
August 30, 2017
Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy
Florence Le Roy, Maximiliano Gelli, Antoine Hollebecque, et al.
BMJ Open
|
November 21, 2022
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial
Jean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll, et al.
Bulletin Du Cancer
|
December 9, 2022
[Prophylaxis and management of cancer-associated thrombosis: Practical issues about anticoagulant use]
David Malka, Nicolas Girard, David M Smadja, et al.
Frontiers in Oncology
|
July 3, 2024
Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis
Julieta E Rodriguez, Damien Vasseur, Mohamed Amine Bani, et al.
Bulletin Du Cancer
|
December 19, 2022
Matthieu Delaye, Eric Assenat, Emmanuel Boleslawski, et al.
Cancer Treatment and Research Communications
|
December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment
Eugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Nature Clinical Practice. Oncology
|
March 20, 2008
Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy
Yohann Loriot, Gabriel Perlemuter, David Malka, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 192) with videos related to
Sort By:
Page
of 20
Bulletin Du Cancer
|
July 1, 2014
[A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blocker]
Marie Wislez, David Malka, Jaafar Bennouna, et al.
Anti-Cancer Drugs
|
December 12, 2018
5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy
Alice Boilève, Camille Wicker, Benjamin Verret, et al.
Oncology
|
January 25, 2012
Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study
Maximilien Barret, David Malka, Thomas Aparicio, et al.
Annals of Surgical Oncology
|
August 30, 2017
Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy
Florence Le Roy, Maximiliano Gelli, Antoine Hollebecque, et al.
BMJ Open
|
November 21, 2022
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial
Jean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll, et al.
Bulletin Du Cancer
|
December 9, 2022
[Prophylaxis and management of cancer-associated thrombosis: Practical issues about anticoagulant use]
David Malka, Nicolas Girard, David M Smadja, et al.
Frontiers in Oncology
|
July 3, 2024
Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis
Julieta E Rodriguez, Damien Vasseur, Mohamed Amine Bani, et al.
Bulletin Du Cancer
|
December 19, 2022
Matthieu Delaye, Eric Assenat, Emmanuel Boleslawski, et al.
Cancer Treatment and Research Communications
|
December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment
Eugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Nature Clinical Practice. Oncology
|
March 20, 2008
Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy
Yohann Loriot, Gabriel Perlemuter, David Malka, et al.
Page
of 20